Implementation and Effectiveness Evaluation of the iPeer2Peer Support Mentorship Program Within Pediatric Thoracic Transplantation

Status: Completed
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

With the on-going presence of a chronic illness, daily immunosuppressive medications, and the need for continuous medical supervision, pediatric transplant recipients face considerable psychosocial stresses. Treatment nonadherence is a major issue in pediatric transplantation and can lead to increased rates of hospitalization, rejection episodes, graft loss and death. An online peer support mentorship program (iPeer2Peer) is proposed as one intervention that could enhance patient care management, increase treatment adherence, reduce social isolation and improve health outcomes for this highly vulnerable population. The proposed trial will determine 1) implementation outcomes of the iPeer2Peer intervention in terms of: (a) feasibility and adoption, (b) acceptability and appropriateness and (c) level of engagement with the program, and 2) effectiveness of the iPeer2Peer intervention on improving health outcomes including disease self-management skills, treatment adherence, quality of life, perceived social support, stress and coping.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 12
Maximum Age: 25
Healthy Volunteers: f
View:

• heart and/or lung transplant recipient,

• at least 4 months post-transplant,

• between the ages of 12 and 25 years,

• able to speak and read English,

• willingness to commit to 5-10 texts and/or calls of 20-30 minutes each over a period of 15 weeks.

Locations
Other Locations
Canada
Hospital for Sick Children
Toronto
Time Frame
Start Date: 2021-05-20
Completion Date: 2023-08-31
Participants
Target number of participants: 34
Treatments
Experimental: iPeer2Peer Program
Participates in the iPeer2Peer Program
Sponsors
Leads: The Hospital for Sick Children
Collaborators: University of Alberta/Stollery Children's Hospital, Enduring Hearts

This content was sourced from clinicaltrials.gov